Innovative Drug Stocks Surge; Sanlian and Baihua Pharma Hit Daily Limits
Innovative drug concept stocks extended their rally on August 7, 2026, with Harbin Sanlian and Baihua Pharma shares surging to the daily price limit during trading. Yuhuan Pharma, Longshen Rongfa, Lifang Pharma and other related counters followed the advance, posting gains as sector momentum continued. The uptrend reflects sustained investor interest in innovative pharmaceutical names, with multiple stocks across the sector participating in the move.
Innovative drug concept stocks continued to climb on August 7, 2026. As of press time, Harbin Sanlian and Baihua Pharma had hit their daily price limits, while Yuhuan Pharma, Longshen Rongfa, Lifang Pharma and other related names followed with gains. The broad-based advance kept the sector in positive territory during the session.